Suchergebnisse - "Wang, Liqin"

PubPharm (356)

21

Angiotensin-(1-9) attenuates adriamycin-induced cardiomyopathy in rats via the angiotensin type 2 receptor

enthalten in: Molecular and cellular biochemistry | 2024

von Ma, H. | Mao, C. | Hu, Y. | +5

22

Drug reaction with eosinophilia and systemic symptoms : Medication adherence and quality of life in survivors

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Jaggers, J. | Samarakoon, U. | King, A. | +7

23

Characteristics of MDR E. coli strains isolated from Pet Dogs with clinic diarrhea : A pool of antibiotic resistance genes and virulence-associated genes

enthalten in: PloS one | 2024

von Yuan, Y. | Hu, Y. | Zhang, X. | +12

24

MiR-134-3p targets HMOX1 to inhibit ferroptosis in granulosa cells of sheep follicles

enthalten in: Journal of ovarian research | 2024

von Abudureyimu, G. | Wu, Y. | Chen, Y. | +6

25

Caesalpinflavans D-F and caesalpinnone B, hybrid flavan-chalcones and normonoterpene-chalcone heterodimer from Caesalpinia digyna

enthalten in: Phytochemistry | 2024

von Duan, C. | Qin, H. | Bi, D. | +4

26

Retrospective cohort study of neonatal blood transfusion in China

enthalten in: BMC pediatrics | 2023

von Ma, T. | Sun, Y. | Wang, Q. | +8

27

Retrospective cohort study of neonatal blood transfusion in China

enthalten in: BMC pediatrics | 2023

von Ma, T. | Sun, Y. | Wang, Q. | +8

28

A deep learning approach for transgender and gender diverse patient identification in electronic health records

enthalten in: Journal of biomedical informatics | 2023

von Hua, Y. | Wang, L. | Nguyen, V. | +5

29

INDUCERS OF SENESCENCE, IN COMBINATION WITH A SELECTIVE DEATH RECEPTOR 5 (DR5) AGONIST, FOR USE IN A METHOD OF TREATING CANCER

enthalten in: Europäisches Patentamt | 2023

von BERNARDS RENE | WANG LIQIN

30

INDUCERS OF SENESCENCE, IN COMBINATION WITH A SELECTIVE DEATH RECEPTOR 5 (DR5) AGONIST, FOR USE IN A METHOD OF TREATING CANCER

enthalten in: Europäisches Patentamt | 2023

von BERNARDS RENE | WANG LIQIN